Ligands have various potential effects on the degradation of pregnane X receptor by proteasome

Endocrinology

Volumn 143, Issue 1, 2002, Pages 55-61

  Masuyama, Hisashi ^a   Inoshita, Hideshi ^a   Hiramatsu, Yuji ^a   Kudo, Takafumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; NONYLPHENOL; PHTHALIC ACID; PREGNANE X RECEPTOR; PROTEASOME; PROTEIN DERIVATIVE; PROTEIN SUG1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

EID: 0036144190     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.1.8578     Document Type: Article

References (39)

1. A report of the US EPA-sponsored workshop
2. Endocrine disrupters and reproductive development: A weight-of-evidence overview
3. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway
4. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
5. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction
6. Rat pregnane X receptor: Molecular cloning, tissue distribution, and xenobiotic regulation
7. SXR, a novel steroid and xenobiotic-sensing nuclear receptor
8. Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene
9. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element
10. Cytochrome P450, ontogeny and drug disposition
11. The emerging role of cytochrome P450 3A in psychopharmacology
12. Endocrine disrupting chemicals phthalic acid and nonylphenol activate pregnane X receptor-mediated transcription
13. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
14. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
15. Interaction of thyroid-hormone receptor with a conserved transcriptional mediator
16. The RXR heterodimers and orphan receptors
17. Nuclear receptor coactivators and corepressors
18. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction
19. Alternations in a yeast protein resembling HIV Tat-binding protein relieve requirement for an acidic activation domain in GAL4
20. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1
21. Identification of the gal4 suppressor SUG1 as a subunit of the yeast 26S proteasome
22. Proteasome-mediated degradation of the vitamin D receptor (VDR) and a putative role for SUG1 interaction with the Af-2 domain of VDR
23. The retinoblastoma protein associates with the protein phosphatase type I catalytic subunit
24. The N-terminal domain of transcription factor IIB is required for direct interaction with vitamin D receptor and participates in vitamin D-mediated transcription
25. A high-efficiency HeLa cell nuclear transcription extract
26. The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse
27. Mechanistic Studies on the inactivation of the proteasome by lactacystin
28. Inhibitors of the proteasome block the degradation of most ceil proteins and the generation of peptides presented on MHC class I molecules
29. 3 results from ligand-induced stabilization
30. 3
31. The estrogenic activity of phthalate esters in vitro
32. Proteasome
33. The proteasome-dependent proteolytic system
34. Proteasome-dependent degradation of the human estrogen receptor
35. Evidence for enhanced ubiquitin-mediated proteolysis of chicken progesterone receptor by progesterone
36. 9-Cis-retinoic acid decreases the level of its cognate receptor, retinoid receptor, through acceleration of the turnover
37. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells
38. Bisphenol A: An estrogenic substance is released from polycarbonate flasks during autoclaving
39. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats